How we approach conservative treatment of retinoblastoma in South America in the era of local ocular treatments: A consensus of the Grupo America Latina de Oncologia Pediatrica (GALOP)
Por:
Garin JPL, Sampor C, Grigorovski N, Ceciliano A, Fandiño A, Ossandon D, Perez V, Caixeta R, Neto JCA, Alarcón S, Silva S, Teixeira L, Antoneli CG, Mattosinho C, Leal-Leal C, Castela G, Requejo F, Català-Mora J, Macedo C and Chantada G
Publicada:
1 jul 2023
Ahead of Print:
1 abr 2023
Resumen:
Local therapies are increasingly used for ocular preservation in retinoblastoma. In middle-income countries, these techniques pose specific challenges mostly related to more advanced disease at diagnosis. The Grupo de America Latina de Oncologia Pediatrica (GALOP) developed a consensus document for the management of conservative therapy for retinoblastoma. Intra-arterial chemotherapy (OAC) is the preferred therapy, except for those with less advanced disease or age younger than 6 months. OAC allowed for a reduction in the use of external beam radiotherapy in our setting. Intravitreal chemotherapy is the preferred treatment for vitreous seeding. Enucleation is the treatment of choice for eyes with advanced disease.
Filiaciones:
Garin JPL:
Department of ophthalmology, Universidad de Chile, Santiago, Chile
Sampor C:
Hematology-Oncology Service, Hospital de Pediatría SAMIC Juan P Garrahan, Buenos Aires, Argentina
Grigorovski N:
Pediatric Oncology Service, Instituto Nacional do Cancer, INCA, Rio de Janeiro, Brazil
Ceciliano A:
Interventional Neuroradiology, Hospital Universitario Austral, Pilar, Argentina
Fandiño A:
Ophthalmology Service, Clínica Alemana de, Santiago, Chile
Ossandon D:
Ophthalmology Service, Clínica Alemana de, Santiago, Chile
Ophthalmology Service, Hospital San Juan de Dios, Santiago, Chile
Perez V:
Pediatric Oncology Service, Hospital Santa Casa, Belo Horizonte, Brazil
Caixeta R:
Ophthalmology Service, Hospital San Juan de Dios, Santiago, Chile
Neto JCA:
Pediatric Oncology Service, Hospital Santa Casa, Belo Horizonte, Brazil
Alarcón S:
Pediatric Oncology Service, Instituto Nacional de Enfermedades Neoplasicas, INEN, Lima, Peru
Silva S:
Pediatric Oncology Service, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal
Teixeira L:
Ophthalmology Service, Universidade Federal de Sao Paulo Escola Paulista de Medicina, Sao Paulo, Brazil
Antoneli CG:
Pediatric Oncology, Universidade Nove de Julho, Sao Paulo, Brazil
Mattosinho C:
Pediatric Oncology Service, Instituto Nacional do Cancer, INCA, Rio de Janeiro, Brazil
Leal-Leal C:
Pediatric Oncology Service, Hospital Infantil Privado, Mexico City, Mexico
Castela G:
Pediatric Oncology Service, Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal
Requejo F:
Hematology-Oncology Service, Hospital de Pediatría SAMIC Juan P Garrahan, Buenos Aires, Argentina
Català-Mora J:
Ophthalmology Service, Hospital Sant Joan de Deu, Barcelona, Spain
Macedo C:
Pediatric Oncology, Universidade Nove de Julho, Sao Paulo, Brazil
Chantada G:
Interventional Neuroradiology, Hospital Universitario Austral, Pilar, Argentina
Ophthalmology Service, Hospital Sant Joan de Deu, Barcelona, Spain
Instituto de Investigacion en Medicina Traslacional, IIMT, Universidad Austral-CONICET, Pilar, Argentina
Green Submitted
|